Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1956 Oct;49(10):849–852. doi: 10.1177/003591575604901027

Reserpine: Problems Associated with the Use of a So-called “Tranquillizing Agent”

Michael Shepherd
PMCID: PMC1889208  PMID: 19993892

Full text

PDF
849

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARSA J. A., KLINE N. S. Use of reserpine in disturbed psychotic patients. Am J Psychiatry. 1956 Mar;112(9):684–691. doi: 10.1176/ajp.112.9.684. [DOI] [PubMed] [Google Scholar]
  2. CHEN G., ENSOR C. R., BOHNER B. A facilitation action of reserpine on the central nervous system. Proc Soc Exp Biol Med. 1954 Jul;86(3):507–510. doi: 10.3181/00379727-86-21149. [DOI] [PubMed] [Google Scholar]
  3. COLE J., GLEES P. Ritalin as an antagonist to reserpine in monkeys. Lancet. 1956 Mar 24;270(6917):338–338. doi: 10.1016/s0140-6736(56)91668-3. [DOI] [PubMed] [Google Scholar]
  4. DAVIES D. L., SHEPHERD M. Reserpine in the treatment of anxious and depressed patients. Lancet. 1955 Jul 16;269(6881):117–120. doi: 10.1016/s0140-6736(55)92118-8. [DOI] [PubMed] [Google Scholar]
  5. FOSTER M. W., Jr, GAYLE R. F., Jr Dangers in combining reserpine (serpasil) with electroconvulsive therapy. J Am Med Assoc. 1955 Dec 17;159(16):1520–1522. doi: 10.1001/jama.1955.02960330020006. [DOI] [PubMed] [Google Scholar]
  6. KINROSS-WRIGHT V. Chlorpromazine and reserpine in the treatment of psychoses. Ann N Y Acad Sci. 1955 Apr 15;61(1):174–182. doi: 10.1111/j.1749-6632.1955.tb42464.x. [DOI] [PubMed] [Google Scholar]
  7. KOVITZ B., CARTER J. T., ADDISON W. P. A comparison of chlorpromazine and reserpine in chronic psychosis. AMA Arch Neurol Psychiatry. 1955 Nov;74(5):467–471. doi: 10.1001/archneurpsyc.1955.02330170001001. [DOI] [PubMed] [Google Scholar]
  8. MACLEAN P. D., FLANIGAN S., FLYNN J. P., KIM C., STEVENS J. R. Hippocampal function: tentative correlations of conditioning, EEG, drug, and radioautographic studies. Yale J Biol Med. 1955 Dec;28(3-4):380–395. [PMC free article] [PubMed] [Google Scholar]
  9. MIELKE F. A. Uber das Rauwolfia-Alkaloid Reserpin (Serpasil) in der Psychiatrie. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1956;194(3):263–288. doi: 10.1007/BF00352726. [DOI] [PubMed] [Google Scholar]
  10. RINALDI F., HIMWICH H. E. A comparison of effects of reserpine and some barbiturates on the electrical activity of cortical and subcortical structures of the brain of rabbits. Ann N Y Acad Sci. 1955 Apr 15;61(1):27–35. doi: 10.1111/j.1749-6632.1955.tb42449.x. [DOI] [PubMed] [Google Scholar]
  11. RINALDI F., RUDY L. H., HIMWICH H. E. Clinical evaluation of azacyclonol, chlorpromazine, and reserpine on a group of chronic psychotic patients. Am J Psychiatry. 1956 Mar;112(9):678–683. doi: 10.1176/ajp.112.9.678. [DOI] [PubMed] [Google Scholar]
  12. VON FELSINGER J. M., LASAGNA L., BEECHER H. K. Drug-induced mood changes in man. II. Personality and reactions to drugs. J Am Med Assoc. 1955 Mar 26;157(13):1113–1119. doi: 10.1001/jama.1955.02950300041009. [DOI] [PubMed] [Google Scholar]
  13. WING L. The use of reserpine in chronic psychotic patients: a controlled trial. J Ment Sci. 1956 Jul;102(428):530–541. doi: 10.1192/bjp.102.428.530. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES